GB Patent

GB2111043A — Novel cephalosporin esters

Assigned to Novartis AG · Expires 1983-06-29 · 43y expired

What this patent protects

Patent listed against Sustiva.

Drugs covered by this patent

Sustiva (EFAVIRENZ) · Bristol-Myers Squibb

Patent Metadata

Patent number: GB2111043A
Jurisdiction: GB
Classification: —
Expires: 1983-06-29
Drug substance claim: No
Drug product claim: No
Assignee: Novartis AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.